Löwenberg, B., Muus, P., Ossenkoppele, G., Rousselot, P., Cahn, J., Ifrah, N., . . . Kantarjian, H. (2011). Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia. American Society of Hematology.
Citação norma ChicagoLöwenberg, Bob, et al. Phase 1/2 Study to Assess the Safety, Efficacy, and Pharmacokinetics of Barasertib (AZD1152) in Patients With Advanced Acute Myeloid Leukemia. American Society of Hematology, 2011.
Citação norma MLALöwenberg, Bob, et al. Phase 1/2 Study to Assess the Safety, Efficacy, and Pharmacokinetics of Barasertib (AZD1152) in Patients With Advanced Acute Myeloid Leukemia. American Society of Hematology, 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.